FERRARI, Anna
 Distribuzione geografica
Continente #
EU - Europa 28.075
NA - Nord America 24.745
AS - Asia 10.674
SA - Sud America 1.833
AF - Africa 292
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 32
Totale 65.703
Nazione #
US - Stati Uniti d'America 24.291
IT - Italia 17.624
GB - Regno Unito 3.949
CN - Cina 3.125
SG - Singapore 2.951
BR - Brasile 1.370
NL - Olanda 1.361
VN - Vietnam 1.314
HK - Hong Kong 1.243
SE - Svezia 880
DE - Germania 860
FR - Francia 694
UA - Ucraina 656
FI - Finlandia 541
RU - Federazione Russa 437
KR - Corea 406
TR - Turchia 392
IN - India 258
BG - Bulgaria 231
CH - Svizzera 222
CA - Canada 203
MX - Messico 157
ID - Indonesia 145
AR - Argentina 129
BD - Bangladesh 117
ES - Italia 91
JP - Giappone 89
IE - Irlanda 84
IQ - Iraq 80
EC - Ecuador 77
ZA - Sudafrica 68
PL - Polonia 67
PK - Pakistan 66
CO - Colombia 64
CL - Cile 60
IR - Iran 55
AU - Australia 48
BE - Belgio 46
EG - Egitto 45
CZ - Repubblica Ceca 43
MY - Malesia 43
PH - Filippine 43
AE - Emirati Arabi Uniti 42
MA - Marocco 42
PE - Perù 40
SA - Arabia Saudita 39
TW - Taiwan 36
VE - Venezuela 36
UZ - Uzbekistan 33
GR - Grecia 31
TN - Tunisia 31
PY - Paraguay 29
AT - Austria 25
DZ - Algeria 25
KE - Kenya 25
EU - Europa 24
RO - Romania 24
SK - Slovacchia (Repubblica Slovacca) 24
TH - Thailandia 23
CR - Costa Rica 22
DK - Danimarca 22
HU - Ungheria 22
PT - Portogallo 21
RS - Serbia 21
NP - Nepal 20
LT - Lituania 19
BO - Bolivia 18
DO - Repubblica Dominicana 18
AZ - Azerbaigian 16
JM - Giamaica 16
JO - Giordania 16
IL - Israele 14
NO - Norvegia 12
AL - Albania 11
KZ - Kazakistan 11
NG - Nigeria 11
SN - Senegal 11
OM - Oman 10
BY - Bielorussia 9
ET - Etiopia 9
KG - Kirghizistan 9
LB - Libano 9
PA - Panama 9
PR - Porto Rico 9
UY - Uruguay 9
GE - Georgia 8
MN - Mongolia 8
SI - Slovenia 8
BH - Bahrain 7
LU - Lussemburgo 7
LV - Lettonia 7
QA - Qatar 7
AM - Armenia 6
EE - Estonia 6
HN - Honduras 6
PS - Palestinian Territory 6
YE - Yemen 6
HR - Croazia 5
KW - Kuwait 5
MK - Macedonia 5
Totale 65.625
Città #
Southend 2.835
Ashburn 2.112
Santa Clara 1.969
Milan 1.925
Fairfield 1.875
Singapore 1.841
Woodbridge 1.381
Jacksonville 1.286
Hong Kong 1.218
Chandler 1.146
Houston 963
Hefei 870
Rome 753
Wilmington 735
Ann Arbor 727
Dearborn 708
Seattle 703
Chicago 702
Beijing 658
Cambridge 645
Jersey City 590
San Jose 568
London 502
Turin 490
Los Angeles 488
Nyköping 476
Ho Chi Minh City 437
Seoul 338
Helsinki 329
The Dalles 308
Hanoi 304
Salt Lake City 285
Princeton 255
Florence 247
Modena 241
Genoa 231
Council Bluffs 228
Sofia 220
Brescia 218
Eugene 206
Izmir 199
Bologna 197
New York 182
Lauterbourg 181
San Diego 176
Dallas 154
Moscow 150
Redwood City 144
Elk Grove Village 140
Tampa 128
Naples 123
São Paulo 123
Buffalo 115
Orem 109
Verona 107
Bergamo 103
Shanghai 93
Frankfurt am Main 87
Monza 85
Sterling 85
Jakarta 81
Trenton 80
Falls Church 77
Dublin 76
Des Moines 74
Da Nang 72
Padova 71
Parma 70
Perugia 70
Lancaster 64
Pescara 63
Columbus 61
Palermo 61
Boardman 60
Chennai 60
Tokyo 60
Catania 58
Norwalk 56
Bari 54
Haiphong 54
Guangzhou 53
Miami 53
Brooklyn 50
Munich 50
Trieste 48
Nanjing 46
Venice 46
Fremont 45
Mexico City 45
Dulles 44
Toronto 43
Paris 42
Phoenix 42
Bremen 41
Detroit 41
Reggio Emilia 41
Rio de Janeiro 40
Ancona 37
Lucca 37
Torino 37
Totale 36.897
Nome #
Monitoraggio dei pazienti con uso/abuso alcolico mediante la determinazione dell'Etil glucuronide (EtG) nel capello 10.575
Krokodil: The drug that kills 5.988
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 2.146
Atogepant: an emerging treatment for migraine 959
Allopregnanolone serum levels in female migraineurs 783
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors 720
Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017 665
Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair 506
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 489
Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients 479
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats 477
Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study 452
Effective prophylactic treatments of migraine lower plasma glutamate levels 444
Methadone - metabolism, pharmacokinetics and interactions 441
Past, present, and future prospects of medication-overuse headache classification 426
Tramadol chronic abuse: An evidence from hair analysis by LC tandem MS 418
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study 418
Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients 415
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 410
Clinical pharmacology of topiramate in migraine prevention 409
How children and parents evaluate the headache centre's intervention 403
Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ) 396
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 395
Medication overuse and chronic migraine: a critical review according to clinical pharmacology 394
Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments 393
Monitoring of adherence to headache treatments by means of hair analysis 391
Effect of sumatriptan in different models of pain in rats 389
Similarities and differences between chronic migraine and episodic migraine 379
Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS 378
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 372
Hair analysis to monitor abuse of analgesic combinations containing butalbital and propyphenazone 368
Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments 366
Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy 359
Paracetamol: new vistas of an old drug 355
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 355
Adverse reactions related to drugs for headache treatment: clinical impact 352
Headache: one of the most common and troublesome adverse reactions to drugs. 348
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 346
Diagnostic accuracy of hair analysis for the detection of triptan overuse in migraineurs 338
Analgesic drug taking: Beliefs and behavior among headache patients 314
Le neuropatie da farmaci 311
Basal cutaneous pain threshold in headache patients 307
Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage 307
Paracetamol revisited 307
Farmacologia e Tossicologia 298
Abuse of tramadol in a binge pattern in a young woman 296
Sucrose intake: Increase in non-stressed rats and reduction in chronically stressed rats are both prevented by the gamma-hydroxybutyrate (GHB) analogue, GET73 293
Zopiclone and prazepam dependance: role of hair analysis for the monitoring of treatment in a migraine patient 291
Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report 281
Intrapatient variability of the hair levels of pain medications in chronic migraine patients - a pilot study 277
Focus on headache as an adverse reaction to drugs 275
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 274
Pharmacokinetics of indomethacin in chronic migraine patients after withdrawal from the overused combination of indomethacin, Prochlorperazine and caffeine 267
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 264
Abuso di sostanze psicoattive e sistema neuroendocrino dell’adolescente 261
Italian guidelines for primary headaches: 2012 revised version. 260
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. 259
Polypharmacy Among Headache Patients: A Cross-Sectional Study 258
Emerging problems in the pharmacology of migraine: interactions between triptans and drugs for prophylaxis 254
Glutamate receptor antagonists with the potential for migraine treatment 251
Dehydroepiandrosterone Sulfate, Dehydroepiandrosterone, 5α-Dihydroprogesterone and Pregnenolone: Serum Analysis and Correlation Between Migraine and Non-headache Control Females 250
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 249
Analgesic abuse in chronic headache sufferers 247
Pharmacoepidemiology of triptans in a headache centre 247
Proteomic serum profile in menstrual-related and post menopause migraine 245
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 244
Hair testing as a marker of adherence to headache treatments 242
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 241
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 238
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review 237
Different effect of sumatriptan in models of thermal, chemical or cephalalgic pain, in rats 235
Adolescenza, sostanze stupefacenti, riti di passaggio 233
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study 230
Assessment of the efficacy and tolerability of triptans in clinical practice 229
Activity of cromolyn sodium in dietary migraine: a double-blind placebo controlled multicenter trial 228
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 227
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 225
Accanimento terapeutico o riduzione del danno 225
Evalutation of proteomic profile in menstrually-related migraine 225
Tramadol Abuse in a Binge Pattern in a Young Depressed Woman 224
Azioni, interazioni, controindicazioni, tossicità dei farmaci utilizzati nella terapia dell'emicrania 223
Plasma glutathione level in chronic headache drug abuser patients 222
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 222
Clinical considerations preliminary to application of the Italian Society for the Study of Headache’s guidelines regarding migraine prophylactic treatment 219
Trattamento farmacologico del dolore postoperatorio 218
Hypertension and migraine comorbidity: Prevalence and risk of cerebrovascular events: Evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study) 217
Trattamento farmacologico integrato per la terapia delle tossicodipendenze 212
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 211
Evaluation of proteomic profile in menstrual-related migraine 208
Proteomic serum profile of female migraineurs 208
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 208
Zopiclone and prazepam abuse in a chronic migraine patient 206
Dehydroepiandrosterone sulfate, dehydroepiandrosterone, 5α-dihydroprogesterone and pregnenolone in women with migraine: analysis of serum levels and correlation with age, migraine years and frequency 206
Folate, vitamin B12, and serum homocysteine levels in patients with chronic migraine and medication-overuse headache 201
Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients 200
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 199
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study 198
Storia della Sindrome di Neri Barrè 196
Adverse event from drugs commonly employed in the headache attack treatment and prophylaxis: reuslts from a pharmacovigilance survey 193
Psycological profiles in tobacco and drug abusers 192
Totale 49.482
Categoria #
all - tutte 190.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 190.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021701 0 0 0 0 0 0 0 0 0 0 448 253
2021/20224.493 169 519 430 465 191 223 256 296 449 315 568 612
2022/20235.226 494 438 281 409 526 604 248 531 682 252 426 335
2023/20246.492 276 362 371 578 746 468 719 722 389 501 685 675
2024/202512.633 679 491 494 937 1.951 1.498 1.029 909 1.428 869 1.196 1.152
2025/202619.746 1.890 1.183 1.817 2.773 3.635 1.370 2.194 1.255 1.611 1.573 445 0
Totale 65.966